FMP
May 16, 2025 4:35 PM - Davit Kirakosyan
Image credit: FMP
B. Riley initiated coverage on IMAX Corporation (NYSE:IMAX) with a Buy rating and a $36 price target, citing strong momentum across global box office trends, system growth, and an improving content pipeline.
The firm raised its 2025 and 2026 adjusted EBITDA forecasts, pointing to key catalysts including outperformance in China’s Q1 box office, strong system installations, and early signs of a robust domestic box office in Q2. Operating leverage from higher volume is also expected to boost profitability.
Analysts view IMAX as a high-conviction opportunity, driven by a favorable film slate featuring numerous franchise blockbusters tailored for premium formats, an increasing number of “Filmed for IMAX” releases, and growing contributions from local-language content that enhance geographic balance.
B. Riley also highlighted a large global total addressable market, with upside potential from system expansion in underpenetrated regions, and an industry-wide shift toward premium large-format (PLF) experiences, which IMAX is well-positioned to capitalize on.
Sep 10, 2024 7:33 AM - Parth Sanghvi
When it comes to downloading historical stock data, Yahoo Finance has been a popular choice for many. However, for those looking for more comprehensive, accurate, and flexible options, Financial Modeling Prep (FMP) offers a suite of powerful tools and services that stand out as superior alternatives...
Nov 8, 2024 5:30 AM - Sanzhi Kobzhan
When it comes to investing in stocks, one of the key decisions an investor must make involves determining the intrinsic value of a company's shares. Equity valuation isn't just about numbers, it's an art mixed with science, aiming to predict future performance based on current and historical data. H...
Nov 22, 2024 5:08 AM - Parth Sanghvi
Fundamental analysis is one of the most essential tools for investors and analysts alike, helping them assess the intrinsic value of a stock, company, or even an entire market. It focuses on the financial health and economic position of a company, often using key data such as earnings, expenses, ass...